1. Home
  2. NICE vs RGEN Comparison

NICE vs RGEN Comparison

Compare NICE & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NICE Ltd

NICE

NICE Ltd

HOLD

Current Price

$97.26

Market Cap

6.4B

Sector

Technology

ML Signal

HOLD

Logo Repligen Corporation

RGEN

Repligen Corporation

HOLD

Current Price

$119.75

Market Cap

6.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NICE
RGEN
Founded
1986
1981
Country
Israel
United States
Employees
9626
N/A
Industry
Computer Software: Prepackaged Software
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.4B
6.6B
IPO Year
N/A
1995

Fundamental Metrics

Financial Performance
Metric
NICE
RGEN
Price
$97.26
$119.75
Analyst Decision
Buy
Buy
Analyst Count
13
11
Target Price
$158.85
$172.91
AVG Volume (30 Days)
411.3K
827.6K
Earning Date
05-14-2026
04-28-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
286.96
EPS
N/A
0.86
Revenue
N/A
$141,236,000.00
Revenue This Year
$10.14
$14.30
Revenue Next Year
$9.62
$14.52
P/E Ratio
$11.21
$139.53
Revenue Growth
N/A
35.10
52 Week Low
$94.65
$109.66
52 Week High
$180.61
$175.77

Technical Indicators

Market Signals
Indicator
NICE
RGEN
Relative Strength Index (RSI) 27.00 49.60
Support Level $96.83 $111.29
Resistance Level $117.17 $131.81
Average True Range (ATR) 4.49 4.70
MACD -1.35 1.58
Stochastic Oscillator 5.92 79.74

Price Performance

Historical Comparison
NICE
RGEN

About NICE NICE Ltd

Nice is an enterprise software company that serves the customer engagement and financial crime and compliance markets. Software is deployed primarily on the cloud, but also on premises. Within customer engagement, Nice's CXone is the leading CCaaS platform providing solutions such as call routing, interactive voice response, digital self-service, and workforce engagement management. Within financial crime and compliance, Nice offers risk and investigation management, fraud prevention, anti-money-laundering, and compliance solutions.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category (about 55% of total revenue), while chromatography, proteins, and process analytics are 21%, 11%, and 13%, respectively. Customers in North America, Europe, and Asia Pacific contribute about 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: